Page last updated: 2024-10-24

carteolol and Glaucoma

carteolol has been researched along with Glaucoma in 39 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research Excerpts

ExcerptRelevanceReference
"Systemic effects of two topical B adrenergic blocking agents, carteolol and metipranolol, recently introduced in the treatment of open angle chronic glaucoma, were investigated in two groups of 10 asthmatic patients, according to a controlled trial device."9.06[Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics]. ( Dufier, JL; Hugues, FC; Le Jeunne, C; Munera, Y, 1987)
"In patients with normal-tension glaucoma (NTG), topical dorzolamide might enhance the vessel density (VD), topical carteolol decreased the VD in the inferior-temporal peripapillary retina, whereas topical brimonidine did not change the VD."8.02Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated With Carteolol, Brimonidine, or Dorzolamide. ( Chen, LC; Chuang, LH; Huang, SM; Lin, YH; Su, WW, 2021)
"The purpose of the study was to evaluate influence of betaxolol, brimonidine and carteolol in the progression of the visual field defects during time at patients with normotensive glaucoma (NTG)."7.96Betaxolol, Brimonidin and Carteolol in the Therapy of Normal-Tension Glaucoma. ( Fůs, M; Lešták, J; Marešová, K; Weissová, I, 2020)
"The therapeutic effects of carteolol hydrochloride were evaluated in the treatment of 44 uveitis patients (51 eyes) with intraocular pressure elevation or secondary glaucoma."7.67Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis. ( Ichiishi, A; Matsuda, H; Ohno, S, 1989)
"Carteolol is a nonselective beta-blocker with intrinsic sympathomimetic activity (I."6.67A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants. ( Goethals, M; Missotten, L; Vandeputte, O; Vercruysse, K, 1992)
"Carteolol is a nonselective adrenergic blocking agent."5.31Color Doppler imaging of retrobulbar hemodynamics after topical carteolol in normal tension glaucoma. ( Chen, MJ; Ching, J; Chiou, HJ; Chou, K; Hsu, WM, 2001)
"Systemic effects of two topical B adrenergic blocking agents, carteolol and metipranolol, recently introduced in the treatment of open angle chronic glaucoma, were investigated in two groups of 10 asthmatic patients, according to a controlled trial device."5.06[Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics]. ( Dufier, JL; Hugues, FC; Le Jeunne, C; Munera, Y, 1987)
" Its effect on intraocular pressure and heart rate was tested in a comparison with timolol maleate, as was subjective tolerance of it, in 28 eyes (14 subjects) with either ocular hypertension or simple chronic open-angle glaucoma."5.06[Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops]. ( Flury, H; Martenet, AC; Tournoux, A, 1986)
" Ophthalmic carteolol eye drops are nonselective beta-blockers and effective against glaucoma and ocular hypertension."4.31Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops. ( Akashi, R; Eto, R; Ikeda, S; Kawano, H; Maemura, K; Suzuki, A, 2023)
"To investigate the treatment persistence of carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution (CAR/LAT) and other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions (BB/FP) in the treatment of glaucoma."4.31Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions. ( Kashiwagi, K; Ouchi, K; Shibasaki, Y; Suginaka, M, 2023)
"In patients with normal-tension glaucoma (NTG), topical dorzolamide might enhance the vessel density (VD), topical carteolol decreased the VD in the inferior-temporal peripapillary retina, whereas topical brimonidine did not change the VD."4.02Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated With Carteolol, Brimonidine, or Dorzolamide. ( Chen, LC; Chuang, LH; Huang, SM; Lin, YH; Su, WW, 2021)
"The purpose of the study was to evaluate influence of betaxolol, brimonidine and carteolol in the progression of the visual field defects during time at patients with normotensive glaucoma (NTG)."3.96Betaxolol, Brimonidin and Carteolol in the Therapy of Normal-Tension Glaucoma. ( Fůs, M; Lešták, J; Marešová, K; Weissová, I, 2020)
"To assess the potential of chitosan (CS) nanoparticles for ocular drug delivery by investigating their intraocular retention by γ-scintigraphy and intraocular pressure reduction."3.80Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits. ( Ali, A; Ali, J; Bhatnagar, A; Kumar, N, 2014)
" These dendrimers react with the neutral form of carteolol (an ocular anti-hypertensive drug used to treat glaucoma) to afford ion pair (saline) species."3.76Designing dendrimers for ocular drug delivery. ( Caminade, AM; Duhayon, C; Elena, PP; Majoral, JP; Malecaze, F; Soler, V; Spataro, G; Turrin, CO, 2010)
"In this study, the various antiglaucoma drugs including betaxolol, timolol, levobunolol, carteolol, brimonidine, dipivefrin, dorzolamide, brinzolamide, latanoprost, unoprostone, and pilocarpine were used to investigate the effects of cellular cytotoxicity in cultured bovine corneal endothelial cells."3.74Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells. ( Hong, SJ; Wang, HZ; Wu, KY, 2007)
" In the present study, we investigated various commercial antiglaucoma drugs including timolol (0."3.72Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells. ( Fong, JC; Hong, SJ; Wang, HZ; Wu, KY, 2003)
"Carteolol is a nonselective beta-blocker with intrinsic sympathomimetic activity (I."2.67A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants. ( Goethals, M; Missotten, L; Vandeputte, O; Vercruysse, K, 1992)
"The carteolol was solved in saline containing additives (0."1.48Enhancement in Corneal Permeability of Dissolved Carteolol by Its Combination with Magnesium Hydroxide Nanoparticles. ( Fukuoka, Y; Ishii, M; Kanai, K; Nagai, N; Okamoto, N; Otake, H; Shimomura, Y; Yamaoka, S, 2018)
"Betaxolol was twice as effective at preventing the effect of IgG (34% to 37%) than that of zymosan (14%), regardless of the presence of BAK."1.32In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system. ( Baudouin, C; Blondin, C; Cholley, B; Haeffner-Cavaillon, N; Hamard, P, 2003)

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-199010 (25.64)18.7374
1990's8 (20.51)18.2507
2000's10 (25.64)29.6817
2010's7 (17.95)24.3611
2020's4 (10.26)2.80

Authors

AuthorsStudies
Eto, R2
Kawano, H2
Suzuki, A2
Akashi, R2
Ikeda, S2
Maemura, K2
Kashiwagi, K1
Ouchi, K1
Shibasaki, Y1
Suginaka, M1
Lešták, J1
Fůs, M1
Weissová, I1
Marešová, K1
Lin, YH1
Su, WW1
Huang, SM1
Chuang, LH1
Chen, LC1
Nagai, N1
Yamaoka, S1
Fukuoka, Y1
Ishii, M1
Otake, H1
Kanai, K1
Okamoto, N1
Shimomura, Y1
Soares, RR1
Razeghinejad, MR1
Chikama, T1
Araie, M2
Nishida, T1
Ali, J1
Bhatnagar, A1
Kumar, N1
Ali, A1
Shapiro, MK1
Gorn, R1
Spataro, G1
Malecaze, F1
Turrin, CO1
Soler, V1
Duhayon, C1
Elena, PP1
Majoral, JP1
Caminade, AM1
Machů, V1
Kawai, K1
Ohashi, H1
Suzuki, T1
Kitagaki, H1
Fujisawa, S1
Hong, SJ3
Wu, KY3
Wang, HZ3
Fong, JC1
Blondin, C1
Hamard, P1
Cholley, B1
Haeffner-Cavaillon, N1
Baudouin, C2
Ignat, F1
Hino, K1
Mori, K1
Sotozono, C1
Ikeda, Y1
Naruse, S1
Ishibashi, T1
Nanjo, Y1
Kinoshita, S1
Malvitte, L1
Montange, T1
Vejux, A1
Bron, AM1
Creuzot-Garcher, C1
Lizard, G1
Henness, S1
Swainston Harrison, T1
Keating, GM1
Ravet, O1
Negishi, C2
Ueda, S1
Kanai, A2
Nakajima, A2
Funahashi, M1
Kitazawa, Y2
Komemushi, S1
Uesugi, Y1
Zimmerman, TJ1
Frishman, WH1
Fuksbrumer, MS1
Tannenbaum, M1
Koseki, N1
Shirato, S1
Yamagami, J1
Giordano-Labadie, F2
Lepoittevin, JP1
Calix, I1
Bazex, J2
Carrière, M1
Schwarze, HP1
Loche, F1
Nino, M1
Suppa, F1
Ayala, F1
Balato, N1
Chen, MJ1
Ching, J1
Chou, K1
Chiou, HJ1
Hsu, WM1
Vercruysse, K1
Goethals, M1
Vandeputte, O1
Missotten, L1
James, IM1
Pillunat, LE1
Stodtmeister, R1
Ohno, S1
Ichiishi, A1
Matsuda, H1
Hugues, FC1
Le Jeunne, C1
Munera, Y1
Dufier, JL1
Schnarr, KD1
Duff, GR1
Newcombe, RG1
Flury, H1
Tournoux, A1
Martenet, AC1

Reviews

5 reviews available for carteolol and Glaucoma

ArticleYear
Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.
    Drugs & aging, 2007, Volume: 24, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Clinical Trials as Topic; Glaucoma; Humans; Instillati

2007
[The deleterious effect of certain surface active agents on the ocular surface].
    Bulletin de la Societe belge d'ophtalmologie, 2007, Issue:304

    Topics: Administration, Topical; Antihypertensive Agents; Carteolol; Epithelium, Corneal; Glaucoma; Humans;

2007
Topical ophthalmic beta blockers: a comparative review.
    Journal of ocular pharmacology, 1993,Winter, Volume: 9, Issue:4

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Drug Tolerance;

1993
Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
    Journal of clinical pharmacology, 1994, Volume: 34, Issue:8

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Levobu

1994
Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
    Survey of ophthalmology, 1989, Volume: 33 Suppl

    Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Heart Rate; Humans; Intraocular Pressur

1989

Trials

7 trials available for carteolol and Glaucoma

ArticleYear
[Influence on ocular surface and intraocular pressure of switching from preservative-containing to preservative-free carteolol hydrochloride ophthalmic solution].
    Nippon Ganka Gakkai zasshi, 2013, Volume: 117, Issue:5

    Topics: Aged; Aged, 80 and over; Carteolol; Corneal Diseases; Female; Glaucoma; Humans; Intraocular Pressure

2013
[Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].
    Nippon Ganka Gakkai zasshi, 1981, Volume: 85, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Carteolol; Clinical Trials as Topic; Dose-Response Relationship,

1981
[Effect of non-surgical ocular hypotensive therapy in normal-tension glaucoma].
    Nippon Ganka Gakkai zasshi, 1997, Volume: 101, Issue:2

    Topics: Carteolol; Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Middle Ag

1997
A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants.
    Bulletin de la Societe belge d'ophtalmologie, 1992, Volume: 245

    Topics: Adult; Aged; Carteolol; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Visual Fi

1992
[Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
    Journal francais d'ophtalmologie, 1987, Volume: 10, Issue:8-9

    Topics: Adult; Asthma; Blood Pressure; Carteolol; Clinical Trials as Topic; Female; Glaucoma; Heart; Heart R

1987
The 12-hour control of intraocular pressure on carteolol 2% twice daily.
    The British journal of ophthalmology, 1988, Volume: 72, Issue:12

    Topics: Aged; Aged, 80 and over; Carteolol; Clinical Trials as Topic; Double-Blind Method; Female; Glaucoma;

1988
[Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
    Klinische Monatsblatter fur Augenheilkunde, 1986, Volume: 188, Issue:6

    Topics: Adult; Aged; Carteolol; Double-Blind Method; Female; Glaucoma; Glaucoma, Open-Angle; Heart Rate; Hum

1986

Other Studies

27 other studies available for carteolol and Glaucoma

ArticleYear
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023
Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions.
    Japanese journal of ophthalmology, 2023, Volume: 67, Issue:6

    Topics: Antihypertensive Agents; Carteolol; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ocular Hype

2023
Betaxolol, Brimonidin and Carteolol in the Therapy of Normal-Tension Glaucoma.
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2020,Spring, Volume: 76, Issue:2

    Topics: Betaxolol; Carteolol; Evoked Potentials, Visual; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular

2020
Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated With Carteolol, Brimonidine, or Dorzolamide.
    Journal of glaucoma, 2021, 08-01, Volume: 30, Issue:8

    Topics: Angiography; Brimonidine Tartrate; Carteolol; Female; Fluorescein Angiography; Glaucoma; Glaucoma, O

2021
Enhancement in Corneal Permeability of Dissolved Carteolol by Its Combination with Magnesium Hydroxide Nanoparticles.
    International journal of molecular sciences, 2018, Jan-17, Volume: 19, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Cornea; Dose-Response Relationship, Drug; Glaucoma;

2018
Efficacy of the combination of carteolol hydrochloride + latanoprost in the treatment of glaucoma and ocular hypertension.
    Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:15

    Topics: Antihypertensive Agents; Carteolol; Drug Therapy, Combination; Female; Glaucoma; Humans; Latanoprost

2018
Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
    International journal of biological macromolecules, 2014, Volume: 65

    Topics: Adhesiveness; Animals; Carteolol; Chitosan; Cornea; Drug Carriers; Glaucoma; Hydroquinones; Intraocu

2014
The possible treatment of migraine with carteolol hydrochloride.
    Headache, 1999, Volume: 39, Issue:2

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Carteolol; Female; Glaucoma; Humans; Middle Ag

1999
Designing dendrimers for ocular drug delivery.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:1

    Topics: Animals; Carboxylic Acids; Carteolol; Dendrimers; Drug Administration Schedule; Drug Carriers; Drug

2010
[The influence of carteolol and pentoxyphylin on the visual field in glaucoma patients--case reports of selected patients].
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2010, Volume: 66, Issue:1

    Topics: Aged; Carteolol; Female; Glaucoma; Humans; Male; Middle Aged; Pentoxifylline; Visual Fields

2010
[Effect of anti-glaucoma drugs on inflammatory cytokine production by human and murine peripheral blood mononuclear cells].
    Nippon Ganka Gakkai zasshi, 2010, Volume: 114, Issue:8

    Topics: Adrenergic beta-Antagonists; Adult; Animals; Carteolol; Cells, Cultured; Enzyme-Linked Immunosorbent

2010
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:3

    Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; D

2003
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
    Current eye research, 2003, Volume: 27, Issue:4

    Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Betaxolol; Carteolol; Complement System Protein

2003
[Neuroprotection and vasoprotection in glaucoma].
    Oftalmologia (Bucharest, Romania : 1990), 2004, Volume: 48, Issue:2

    Topics: Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Carteolol; Drug Therapy, Combination; Glau

2004
[A case of severe glaucoma with pseudopemphigoid successfully treated by filtration surgery using amniotic membrane].
    Nippon Ganka Gakkai zasshi, 2006, Volume: 110, Issue:4

    Topics: Aged, 80 and over; Amnion; Carteolol; Filtering Surgery; Glaucoma; Humans; Male; Pemphigoid, Bullous

2006
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.
    The British journal of ophthalmology, 2007, Volume: 91, Issue:1

    Topics: Administration, Topical; Aged; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; C

2007
Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells.
    The Kaohsiung journal of medical sciences, 2007, Volume: 23, Issue:3

    Topics: Animals; Betaxolol; Carteolol; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelia

2007
[Studies on the treatment of glaucomatous eyes with carteolol ophthalmic solution (author's transl)].
    Nippon Ganka Gakkai zasshi, 1981, May-10, Volume: 85, Issue:5

    Topics: Adult; Aged; Carteolol; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Propanola

1981
Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1997, Volume: 13, Issue:1

    Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Cell Division; Cells, Cultured; Eye; Fibroblasts;

1997
[Contact allergy to beta blockaders in eye drops: cross allergy?].
    Annales de dermatologie et de venereologie, 1997, Volume: 124, Issue:4

    Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Cross Reactions; Dermatitis, Contact; Eyelid Diseases;

1997
Difficulties in the interpretation of patch test reactions to ophthalmic beta-blockers.
    Contact dermatitis, 1998, Volume: 39, Issue:6

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Carteolol; Conjunctivitis, Allergic; Der

1998
Allergic contact dermatitis due to the beta-blocker befunolol in eyedrops, with cross-sensitivity to carteolol.
    Contact dermatitis, 2001, Volume: 44, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Dermatitis, Allergic Contact; Female; Glaucoma; Humans

2001
Color Doppler imaging of retrobulbar hemodynamics after topical carteolol in normal tension glaucoma.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 2001, Volume: 64, Issue:10

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Carteolol; Female; Glaucoma; Hemodynamic

2001
Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
    Survey of ophthalmology, 1989, Volume: 33 Suppl

    Topics: Acetazolamide; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Glaucoma, Open-Angle; Hu

1989
Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1989, Volume: 199, Issue:1

    Topics: Adolescent; Adult; Aged; Blood Pressure; Carteolol; Child; Drug Administration Schedule; Female; Gla

1989
New topical beta-blockers for glaucoma.
    Drug and therapeutics bulletin, 1987, Aug-10, Volume: 25, Issue:16

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Metipr

1987
[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
    Klinische Monatsblatter fur Augenheilkunde, 1988, Volume: 192, Issue:2

    Topics: Adrenergic beta-Antagonists; Carteolol; Drug Evaluation; Glaucoma; Humans; Intraocular Pressure; Met

1988